The Automated and Closed Cell Therapy Processing System Market is expected to increase from USD 1199.14 billion in 2023 to USD 9350.92 billion in 2033. The increasing number of investments in cell processing technology has prompted many manufacturers to combine various software technologies in the market for automated and cell treatment processing systems
Cell therapy is a treatment method that involves replacing any malfunctioning or sick cells with active and functional cells. Because stem cells can be developed into specific cells required for healing damaged or faulty tissues or cells, they are used in these sophisticated therapies.
Because of the rapidly increasing worldwide pharmaceutical sector, the global automated and closed-cell therapy processing system market is likely to grow significantly over the forecast period. In recent years, the revolutionization of gene therapy and cell treatment has aided market expansion. The increased commercialization of cell treatments around the world is expected to drive market expansion in the future years.
Request a Sample Copy of This Report!
https://www.futuremarketinsights.com/reports/sample/rep-gb-16106
The use of automated and closed-cell therapy processing systems has significantly lowered labor costs. This element is also thought to provide economic advantages to the market. At the same time, factors such as increased demand for regenerative medicines and tailored therapies around the world are propelling the market growth further.
The automated and closed cell therapy processing systems have increased the pace of manufacturing while maintaining high-quality outputs which support the market’s growth. However, the time-consuming and costly cell therapy manufacturing process is thought to limit market expansion.
Key Points from the Automated and Closed Cell Therapy Processing System Market
- The market is expected to surpass US$ 9350.92 billion by 2033.
- The diversity of benefits provided by automation technologies for the development of cell therapies is the crucial reason driving market expansion.
- Automated and closed cell therapy processing system industry is expected to capture a CAGR of 22.8% during the forecast period from 2023 to 2033.
- North America dominated the automated and closed cell therapy processing system industry.
Key Developments in the Automated and Closed Cell Therapy Processing System Market
- October 2021 – Terumo teamed with Bio Centriq laboratories, a clinical production centre for cell and gene therapies. This collaboration sought to bring together the companies’ respective automation and CDMO knowledge, products, talents, and services to meet users where they are in their product development pathway and provide for a future scalable strategy.
- July 2021 – Cellares Corporation signed a deal with Poseida Therapeutics, a clinical-stage biopharmaceutical startup. Poseida has joined Cellares’ Early Access Partnership Program as a result of this partnership (EAPP).
- June 2021 – Lonza has partnered with CellPoint, a private, clinical-stage Biopharmaceutical Company. The goal of this partnership was to create multiple T-cell-based medicines quickly and to use the Cocoon Platform for clinical point-of-care manufacturing. The use of the Cocoon Platform, together with CellPoints’ medicines and technologies and Lonza’s manufacturing capabilities, might help to accelerate the approach to the clinic and provide a smooth path to commercial approval.
- May 2021 – Cytiva joined Multiply Labs, a pioneer in designing robotic systems for pharmaceutical manufacturing. The goal of this partnership was to create a robotic manufacturing system that would automate the manual aspects of the cell therapy manufacturing cycle.
- August 2020 – Lonza announced a relationship with IsoPlexis, a life science technology business. This collaboration is intended to advance cell therapy manufacturing.
Purchase The Full Report Now!
https://www.futuremarketinsights.com/checkout/16106
Key Companies Operating in the Automated and Closed Cell Therapy Processing System Market
- Miltenyi Bio tec
- Lonza
- Fresenius Kabi
- Cytiva
- Bio Spherix
- Terumo
- Cellares
- Sartorius
Automated and Closed Cell Therapy Processing System Industry Key Segmentation
By Type:
- Stem Cell Therapy
- Non-Stem Cell Therapy
By Workflow:
- Separation
- Expansion
- Apheresis
- Fill-Finish
- Cryopreservation
By Scale:
- Pre-commercial/Research and Development Scale
- Commercial Scale
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
